nodes	percent_of_prediction	percent_of_DWPC	metapath
Mexiletine—AHR—breast cancer	0.208	0.459	CbGaD
Mexiletine—SCN10A—breast cancer	0.156	0.345	CbGaD
Mexiletine—CYP2D6—breast cancer	0.048	0.106	CbGaD
Mexiletine—CYP3A4—breast cancer	0.0412	0.0908	CbGaD
Mexiletine—CYP2B6—Thiotepa—breast cancer	0.0297	0.094	CbGbCtD
Mexiletine—CYP1A2—Anastrozole—breast cancer	0.023	0.0727	CbGbCtD
Mexiletine—CYP1A2—Toremifene—breast cancer	0.021	0.0665	CbGbCtD
Mexiletine—CYP2B6—Raloxifene—breast cancer	0.0198	0.0627	CbGbCtD
Mexiletine—CYP3A4—Exemestane—breast cancer	0.0159	0.0503	CbGbCtD
Mexiletine—CYP2D6—Idarubicin—breast cancer	0.0144	0.0454	CbGbCtD
Mexiletine—CYP3A4—Letrozole—breast cancer	0.0135	0.0428	CbGbCtD
Mexiletine—CYP2E1—Tamoxifen—breast cancer	0.0133	0.042	CbGbCtD
Mexiletine—CYP2B6—Tamoxifen—breast cancer	0.0131	0.0415	CbGbCtD
Mexiletine—CYP2E1—Mitoxantrone—breast cancer	0.0129	0.041	CbGbCtD
Mexiletine—CYP3A4—Anastrozole—breast cancer	0.012	0.0381	CbGbCtD
Mexiletine—CYP3A4—Toremifene—breast cancer	0.011	0.0349	CbGbCtD
Mexiletine—CYP3A4—Fulvestrant—breast cancer	0.0102	0.0324	CbGbCtD
Mexiletine—CYP2B6—Irinotecan—breast cancer	0.0101	0.0318	CbGbCtD
Mexiletine—CYP3A4—Thiotepa—breast cancer	0.00913	0.0289	CbGbCtD
Mexiletine—CYP3A4—Ixabepilone—breast cancer	0.00835	0.0264	CbGbCtD
Mexiletine—CYP3A4—Lapatinib—breast cancer	0.00803	0.0254	CbGbCtD
Mexiletine—CYP1A2—Tamoxifen—breast cancer	0.00768	0.0243	CbGbCtD
Mexiletine—CYP2D6—Vinorelbine—breast cancer	0.00701	0.0222	CbGbCtD
Mexiletine—CYP2D6—Tamoxifen—breast cancer	0.00633	0.02	CbGbCtD
Mexiletine—CYP3A4—Raloxifene—breast cancer	0.00609	0.0193	CbGbCtD
Mexiletine—CYP1A2—Fluorouracil—breast cancer	0.00566	0.0179	CbGbCtD
Mexiletine—CYP2B6—Doxorubicin—breast cancer	0.00549	0.0174	CbGbCtD
Mexiletine—CYP3A4—Vinorelbine—breast cancer	0.00446	0.0141	CbGbCtD
Mexiletine—CYP2D6—Vinblastine—breast cancer	0.00432	0.0137	CbGbCtD
Mexiletine—CYP3A4—Tamoxifen—breast cancer	0.00402	0.0127	CbGbCtD
Mexiletine—CYP3A4—Mitoxantrone—breast cancer	0.00392	0.0124	CbGbCtD
Mexiletine—CYP3A4—Paclitaxel—breast cancer	0.00313	0.00991	CbGbCtD
Mexiletine—CYP3A4—Irinotecan—breast cancer	0.00309	0.00978	CbGbCtD
Mexiletine—CYP3A4—Vinblastine—breast cancer	0.00275	0.00869	CbGbCtD
Mexiletine—CYP2D6—Doxorubicin—breast cancer	0.00265	0.0084	CbGbCtD
Mexiletine—CYP3A4—Docetaxel—breast cancer	0.00226	0.00717	CbGbCtD
Mexiletine—CYP3A4—Doxorubicin—breast cancer	0.00169	0.00534	CbGbCtD
Mexiletine—Tocainide—SCN10A—breast cancer	0.00113	0.813	CrCbGaD
Mexiletine—AHR—nipple—breast cancer	0.00102	0.0748	CbGeAlD
Mexiletine—AHR—endometrium—breast cancer	0.000617	0.0452	CbGeAlD
Mexiletine—SCN9A—pituitary gland—breast cancer	0.000572	0.0419	CbGeAlD
Mexiletine—SCN9A—adipose tissue—breast cancer	0.00057	0.0417	CbGeAlD
Mexiletine—AHR—uterus—breast cancer	0.000569	0.0416	CbGeAlD
Mexiletine—AHR—pituitary gland—breast cancer	0.000558	0.0409	CbGeAlD
Mexiletine—AHR—adipose tissue—breast cancer	0.000556	0.0407	CbGeAlD
Mexiletine—SCN9A—adrenal gland—breast cancer	0.000511	0.0374	CbGeAlD
Mexiletine—AHR—female reproductive system—breast cancer	0.000511	0.0374	CbGeAlD
Mexiletine—SCN4A—pituitary gland—breast cancer	0.00051	0.0374	CbGeAlD
Mexiletine—SCN4A—adipose tissue—breast cancer	0.000508	0.0372	CbGeAlD
Mexiletine—AHR—adrenal gland—breast cancer	0.000499	0.0365	CbGeAlD
Mexiletine—AHR—bone marrow—breast cancer	0.000482	0.0353	CbGeAlD
Mexiletine—AHR—female gonad—breast cancer	0.000465	0.034	CbGeAlD
Mexiletine—SCN4A—adrenal gland—breast cancer	0.000456	0.0334	CbGeAlD
Mexiletine—SCN2A—pituitary gland—breast cancer	0.000452	0.0331	CbGeAlD
Mexiletine—SCN10A—pituitary gland—breast cancer	0.000436	0.0319	CbGeAlD
Mexiletine—AHR—endocrine gland—breast cancer	0.000432	0.0317	CbGeAlD
Mexiletine—CYP1A2—nipple—breast cancer	0.000381	0.0279	CbGeAlD
Mexiletine—SCN2A—endocrine gland—breast cancer	0.00035	0.0256	CbGeAlD
Mexiletine—SCN10A—endocrine gland—breast cancer	0.000337	0.0247	CbGeAlD
Mexiletine—SCN9A—lymph node—breast cancer	0.000306	0.0224	CbGeAlD
Mexiletine—AHR—lymph node—breast cancer	0.000299	0.0219	CbGeAlD
Mexiletine—Tocainide—ALB—breast cancer	0.000259	0.187	CrCbGaD
Mexiletine—CYP2B6—skin of body—breast cancer	0.000234	0.0171	CbGeAlD
Mexiletine—SCN10A—lymph node—breast cancer	0.000233	0.0171	CbGeAlD
Mexiletine—CYP2B6—female reproductive system—breast cancer	0.000183	0.0134	CbGeAlD
Mexiletine—CYP2B6—adrenal gland—breast cancer	0.000178	0.0131	CbGeAlD
Mexiletine—CYP2E1—female reproductive system—breast cancer	0.000172	0.0126	CbGeAlD
Mexiletine—CYP2E1—adrenal gland—breast cancer	0.000167	0.0123	CbGeAlD
Mexiletine—CYP1A2—endocrine gland—breast cancer	0.000161	0.0118	CbGeAlD
Mexiletine—CYP2B6—endocrine gland—breast cancer	0.000155	0.0113	CbGeAlD
Mexiletine—CYP2E1—endocrine gland—breast cancer	0.000145	0.0106	CbGeAlD
Mexiletine—CYP3A4—female reproductive system—breast cancer	0.000138	0.0101	CbGeAlD
Mexiletine—CYP2D6—female reproductive system—breast cancer	0.000136	0.00995	CbGeAlD
Mexiletine—CYP2D6—female gonad—breast cancer	0.000124	0.00905	CbGeAlD
Mexiletine—CYP3A4—endocrine gland—breast cancer	0.000117	0.00855	CbGeAlD
Mexiletine—CYP2D6—endocrine gland—breast cancer	0.000115	0.00842	CbGeAlD
Mexiletine—Dry mouth—Docetaxel—breast cancer	4.81e-05	0.000369	CcSEcCtD
Mexiletine—Fatigue—Paclitaxel—breast cancer	4.8e-05	0.000368	CcSEcCtD
Mexiletine—Hepatitis—Methotrexate—breast cancer	4.79e-05	0.000367	CcSEcCtD
Mexiletine—Asthenia—Gemcitabine—breast cancer	4.77e-05	0.000365	CcSEcCtD
Mexiletine—Arthralgia—Capecitabine—breast cancer	4.77e-05	0.000365	CcSEcCtD
Mexiletine—Chest pain—Capecitabine—breast cancer	4.77e-05	0.000365	CcSEcCtD
Mexiletine—Pain—Paclitaxel—breast cancer	4.76e-05	0.000365	CcSEcCtD
Mexiletine—Constipation—Paclitaxel—breast cancer	4.76e-05	0.000365	CcSEcCtD
Mexiletine—Confusional state—Docetaxel—breast cancer	4.76e-05	0.000364	CcSEcCtD
Mexiletine—Pharyngitis—Methotrexate—breast cancer	4.75e-05	0.000364	CcSEcCtD
Mexiletine—Oedema—Docetaxel—breast cancer	4.72e-05	0.000361	CcSEcCtD
Mexiletine—Discomfort—Capecitabine—breast cancer	4.71e-05	0.000361	CcSEcCtD
Mexiletine—Nausea—Thiotepa—breast cancer	4.7e-05	0.00036	CcSEcCtD
Mexiletine—Diarrhoea—Mitoxantrone—breast cancer	4.67e-05	0.000358	CcSEcCtD
Mexiletine—Diarrhoea—Irinotecan—breast cancer	4.67e-05	0.000358	CcSEcCtD
Mexiletine—Dry mouth—Capecitabine—breast cancer	4.66e-05	0.000357	CcSEcCtD
Mexiletine—Agranulocytosis—Epirubicin—breast cancer	4.66e-05	0.000357	CcSEcCtD
Mexiletine—Shock—Docetaxel—breast cancer	4.64e-05	0.000355	CcSEcCtD
Mexiletine—Thrombocytopenia—Docetaxel—breast cancer	4.62e-05	0.000354	CcSEcCtD
Mexiletine—Drowsiness—Doxorubicin—breast cancer	4.62e-05	0.000354	CcSEcCtD
Mexiletine—Visual impairment—Methotrexate—breast cancer	4.61e-05	0.000353	CcSEcCtD
Mexiletine—Confusional state—Capecitabine—breast cancer	4.61e-05	0.000353	CcSEcCtD
Mexiletine—Feeling abnormal—Paclitaxel—breast cancer	4.59e-05	0.000351	CcSEcCtD
Mexiletine—Stevens-Johnson syndrome—Doxorubicin—breast cancer	4.58e-05	0.000351	CcSEcCtD
Mexiletine—Oedema—Capecitabine—breast cancer	4.57e-05	0.00035	CcSEcCtD
Mexiletine—Bradycardia—Epirubicin—breast cancer	4.56e-05	0.000349	CcSEcCtD
Mexiletine—Gastrointestinal pain—Paclitaxel—breast cancer	4.55e-05	0.000349	CcSEcCtD
Mexiletine—Diarrhoea—Gemcitabine—breast cancer	4.55e-05	0.000348	CcSEcCtD
Mexiletine—Erythema multiforme—Methotrexate—breast cancer	4.53e-05	0.000347	CcSEcCtD
Mexiletine—Dizziness—Irinotecan—breast cancer	4.51e-05	0.000346	CcSEcCtD
Mexiletine—Shock—Capecitabine—breast cancer	4.5e-05	0.000344	CcSEcCtD
Mexiletine—Hepatitis—Epirubicin—breast cancer	4.48e-05	0.000343	CcSEcCtD
Mexiletine—Diarrhoea—Fluorouracil—breast cancer	4.47e-05	0.000343	CcSEcCtD
Mexiletine—Thrombocytopenia—Capecitabine—breast cancer	4.47e-05	0.000343	CcSEcCtD
Mexiletine—Tinnitus—Methotrexate—breast cancer	4.46e-05	0.000342	CcSEcCtD
Mexiletine—Hypoaesthesia—Epirubicin—breast cancer	4.46e-05	0.000341	CcSEcCtD
Mexiletine—Pharyngitis—Epirubicin—breast cancer	4.45e-05	0.00034	CcSEcCtD
Mexiletine—Hyperhidrosis—Capecitabine—breast cancer	4.42e-05	0.000338	CcSEcCtD
Mexiletine—Hypotension—Docetaxel—breast cancer	4.41e-05	0.000338	CcSEcCtD
Mexiletine—Body temperature increased—Paclitaxel—breast cancer	4.4e-05	0.000337	CcSEcCtD
Mexiletine—Abdominal pain—Paclitaxel—breast cancer	4.4e-05	0.000337	CcSEcCtD
Mexiletine—Vomiting—Mitoxantrone—breast cancer	4.34e-05	0.000332	CcSEcCtD
Mexiletine—Vomiting—Irinotecan—breast cancer	4.34e-05	0.000332	CcSEcCtD
Mexiletine—Dizziness—Fluorouracil—breast cancer	4.32e-05	0.000331	CcSEcCtD
Mexiletine—Visual impairment—Epirubicin—breast cancer	4.32e-05	0.000331	CcSEcCtD
Mexiletine—Agranulocytosis—Doxorubicin—breast cancer	4.31e-05	0.00033	CcSEcCtD
Mexiletine—Rash—Irinotecan—breast cancer	4.3e-05	0.00033	CcSEcCtD
Mexiletine—Rash—Mitoxantrone—breast cancer	4.3e-05	0.00033	CcSEcCtD
Mexiletine—Dermatitis—Mitoxantrone—breast cancer	4.3e-05	0.000329	CcSEcCtD
Mexiletine—Dermatitis—Irinotecan—breast cancer	4.3e-05	0.000329	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Docetaxel—breast cancer	4.3e-05	0.000329	CcSEcCtD
Mexiletine—Headache—Mitoxantrone—breast cancer	4.28e-05	0.000327	CcSEcCtD
Mexiletine—Headache—Irinotecan—breast cancer	4.28e-05	0.000327	CcSEcCtD
Mexiletine—Hypotension—Capecitabine—breast cancer	4.27e-05	0.000327	CcSEcCtD
Mexiletine—Paraesthesia—Docetaxel—breast cancer	4.24e-05	0.000324	CcSEcCtD
Mexiletine—Erythema multiforme—Epirubicin—breast cancer	4.24e-05	0.000324	CcSEcCtD
Mexiletine—Alopecia—Methotrexate—breast cancer	4.23e-05	0.000324	CcSEcCtD
Mexiletine—Vomiting—Gemcitabine—breast cancer	4.23e-05	0.000324	CcSEcCtD
Mexiletine—Bradycardia—Doxorubicin—breast cancer	4.22e-05	0.000323	CcSEcCtD
Mexiletine—Dyspnoea—Docetaxel—breast cancer	4.21e-05	0.000322	CcSEcCtD
Mexiletine—Somnolence—Docetaxel—breast cancer	4.2e-05	0.000321	CcSEcCtD
Mexiletine—Rash—Gemcitabine—breast cancer	4.19e-05	0.000321	CcSEcCtD
Mexiletine—Dermatitis—Gemcitabine—breast cancer	4.19e-05	0.000321	CcSEcCtD
Mexiletine—Tinnitus—Epirubicin—breast cancer	4.18e-05	0.00032	CcSEcCtD
Mexiletine—Headache—Gemcitabine—breast cancer	4.17e-05	0.000319	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Capecitabine—breast cancer	4.16e-05	0.000319	CcSEcCtD
Mexiletine—Vomiting—Fluorouracil—breast cancer	4.16e-05	0.000318	CcSEcCtD
Mexiletine—Dyspepsia—Docetaxel—breast cancer	4.15e-05	0.000318	CcSEcCtD
Mexiletine—Hepatitis—Doxorubicin—breast cancer	4.15e-05	0.000317	CcSEcCtD
Mexiletine—Hypoaesthesia—Doxorubicin—breast cancer	4.12e-05	0.000316	CcSEcCtD
Mexiletine—Rash—Fluorouracil—breast cancer	4.12e-05	0.000316	CcSEcCtD
Mexiletine—Dermatitis—Fluorouracil—breast cancer	4.12e-05	0.000315	CcSEcCtD
Mexiletine—Pharyngitis—Doxorubicin—breast cancer	4.11e-05	0.000315	CcSEcCtD
Mexiletine—Paraesthesia—Capecitabine—breast cancer	4.1e-05	0.000314	CcSEcCtD
Mexiletine—Hypersensitivity—Paclitaxel—breast cancer	4.1e-05	0.000314	CcSEcCtD
Mexiletine—Headache—Fluorouracil—breast cancer	4.1e-05	0.000314	CcSEcCtD
Mexiletine—Dysgeusia—Methotrexate—breast cancer	4.08e-05	0.000312	CcSEcCtD
Mexiletine—Dyspnoea—Capecitabine—breast cancer	4.07e-05	0.000312	CcSEcCtD
Mexiletine—Fatigue—Docetaxel—breast cancer	4.07e-05	0.000312	CcSEcCtD
Mexiletine—Nausea—Mitoxantrone—breast cancer	4.06e-05	0.00031	CcSEcCtD
Mexiletine—Nausea—Irinotecan—breast cancer	4.06e-05	0.00031	CcSEcCtD
Mexiletine—Pain—Docetaxel—breast cancer	4.04e-05	0.000309	CcSEcCtD
Mexiletine—Constipation—Docetaxel—breast cancer	4.04e-05	0.000309	CcSEcCtD
Mexiletine—Dyspepsia—Capecitabine—breast cancer	4.02e-05	0.000308	CcSEcCtD
Mexiletine—Arrhythmia—Epirubicin—breast cancer	4e-05	0.000306	CcSEcCtD
Mexiletine—Visual impairment—Doxorubicin—breast cancer	4e-05	0.000306	CcSEcCtD
Mexiletine—Asthenia—Paclitaxel—breast cancer	3.99e-05	0.000306	CcSEcCtD
Mexiletine—Alopecia—Epirubicin—breast cancer	3.96e-05	0.000303	CcSEcCtD
Mexiletine—Nausea—Gemcitabine—breast cancer	3.95e-05	0.000302	CcSEcCtD
Mexiletine—Fatigue—Capecitabine—breast cancer	3.94e-05	0.000302	CcSEcCtD
Mexiletine—Vision blurred—Methotrexate—breast cancer	3.93e-05	0.000301	CcSEcCtD
Mexiletine—Erythema multiforme—Doxorubicin—breast cancer	3.92e-05	0.0003	CcSEcCtD
Mexiletine—Constipation—Capecitabine—breast cancer	3.91e-05	0.000299	CcSEcCtD
Mexiletine—Pain—Capecitabine—breast cancer	3.91e-05	0.000299	CcSEcCtD
Mexiletine—Feeling abnormal—Docetaxel—breast cancer	3.89e-05	0.000298	CcSEcCtD
Mexiletine—Nausea—Fluorouracil—breast cancer	3.88e-05	0.000297	CcSEcCtD
Mexiletine—Ill-defined disorder—Methotrexate—breast cancer	3.87e-05	0.000296	CcSEcCtD
Mexiletine—Tinnitus—Doxorubicin—breast cancer	3.87e-05	0.000296	CcSEcCtD
Mexiletine—Gastrointestinal pain—Docetaxel—breast cancer	3.86e-05	0.000295	CcSEcCtD
Mexiletine—Tension—Epirubicin—breast cancer	3.83e-05	0.000293	CcSEcCtD
Mexiletine—Dysgeusia—Epirubicin—breast cancer	3.82e-05	0.000292	CcSEcCtD
Mexiletine—Diarrhoea—Paclitaxel—breast cancer	3.81e-05	0.000292	CcSEcCtD
Mexiletine—Nervousness—Epirubicin—breast cancer	3.79e-05	0.00029	CcSEcCtD
Mexiletine—Feeling abnormal—Capecitabine—breast cancer	3.77e-05	0.000288	CcSEcCtD
Mexiletine—Malaise—Methotrexate—breast cancer	3.76e-05	0.000288	CcSEcCtD
Mexiletine—Muscle spasms—Epirubicin—breast cancer	3.75e-05	0.000287	CcSEcCtD
Mexiletine—Gastrointestinal pain—Capecitabine—breast cancer	3.74e-05	0.000286	CcSEcCtD
Mexiletine—Abdominal pain—Docetaxel—breast cancer	3.73e-05	0.000286	CcSEcCtD
Mexiletine—Body temperature increased—Docetaxel—breast cancer	3.73e-05	0.000286	CcSEcCtD
Mexiletine—Leukopenia—Methotrexate—breast cancer	3.73e-05	0.000286	CcSEcCtD
Mexiletine—Arrhythmia—Doxorubicin—breast cancer	3.7e-05	0.000284	CcSEcCtD
Mexiletine—Dizziness—Paclitaxel—breast cancer	3.68e-05	0.000282	CcSEcCtD
Mexiletine—Vision blurred—Epirubicin—breast cancer	3.68e-05	0.000281	CcSEcCtD
Mexiletine—Alopecia—Doxorubicin—breast cancer	3.66e-05	0.00028	CcSEcCtD
Mexiletine—Ill-defined disorder—Epirubicin—breast cancer	3.62e-05	0.000277	CcSEcCtD
Mexiletine—Abdominal pain—Capecitabine—breast cancer	3.61e-05	0.000277	CcSEcCtD
Mexiletine—Body temperature increased—Capecitabine—breast cancer	3.61e-05	0.000277	CcSEcCtD
Mexiletine—Convulsion—Methotrexate—breast cancer	3.61e-05	0.000276	CcSEcCtD
Mexiletine—Chest pain—Methotrexate—breast cancer	3.55e-05	0.000272	CcSEcCtD
Mexiletine—Arthralgia—Methotrexate—breast cancer	3.55e-05	0.000272	CcSEcCtD
Mexiletine—Tension—Doxorubicin—breast cancer	3.54e-05	0.000271	CcSEcCtD
Mexiletine—Vomiting—Paclitaxel—breast cancer	3.54e-05	0.000271	CcSEcCtD
Mexiletine—Dysgeusia—Doxorubicin—breast cancer	3.53e-05	0.000271	CcSEcCtD
Mexiletine—Malaise—Epirubicin—breast cancer	3.52e-05	0.000269	CcSEcCtD
Mexiletine—Rash—Paclitaxel—breast cancer	3.51e-05	0.000269	CcSEcCtD
Mexiletine—Dermatitis—Paclitaxel—breast cancer	3.51e-05	0.000269	CcSEcCtD
Mexiletine—Discomfort—Methotrexate—breast cancer	3.51e-05	0.000268	CcSEcCtD
Mexiletine—Nervousness—Doxorubicin—breast cancer	3.51e-05	0.000268	CcSEcCtD
Mexiletine—Syncope—Epirubicin—breast cancer	3.5e-05	0.000268	CcSEcCtD
Mexiletine—Leukopenia—Epirubicin—breast cancer	3.49e-05	0.000267	CcSEcCtD
Mexiletine—Headache—Paclitaxel—breast cancer	3.49e-05	0.000267	CcSEcCtD
Mexiletine—Hypersensitivity—Docetaxel—breast cancer	3.48e-05	0.000266	CcSEcCtD
Mexiletine—Muscle spasms—Doxorubicin—breast cancer	3.47e-05	0.000266	CcSEcCtD
Mexiletine—Palpitations—Epirubicin—breast cancer	3.45e-05	0.000264	CcSEcCtD
Mexiletine—Confusional state—Methotrexate—breast cancer	3.43e-05	0.000263	CcSEcCtD
Mexiletine—Loss of consciousness—Epirubicin—breast cancer	3.43e-05	0.000262	CcSEcCtD
Mexiletine—Vision blurred—Doxorubicin—breast cancer	3.4e-05	0.00026	CcSEcCtD
Mexiletine—Asthenia—Docetaxel—breast cancer	3.39e-05	0.000259	CcSEcCtD
Mexiletine—Convulsion—Epirubicin—breast cancer	3.38e-05	0.000259	CcSEcCtD
Mexiletine—Hypertension—Epirubicin—breast cancer	3.37e-05	0.000258	CcSEcCtD
Mexiletine—Hypersensitivity—Capecitabine—breast cancer	3.37e-05	0.000258	CcSEcCtD
Mexiletine—Ill-defined disorder—Doxorubicin—breast cancer	3.35e-05	0.000256	CcSEcCtD
Mexiletine—Thrombocytopenia—Methotrexate—breast cancer	3.33e-05	0.000255	CcSEcCtD
Mexiletine—Arthralgia—Epirubicin—breast cancer	3.32e-05	0.000254	CcSEcCtD
Mexiletine—Chest pain—Epirubicin—breast cancer	3.32e-05	0.000254	CcSEcCtD
Mexiletine—Nausea—Paclitaxel—breast cancer	3.31e-05	0.000253	CcSEcCtD
Mexiletine—Hyperhidrosis—Methotrexate—breast cancer	3.29e-05	0.000252	CcSEcCtD
Mexiletine—Discomfort—Epirubicin—breast cancer	3.28e-05	0.000251	CcSEcCtD
Mexiletine—Asthenia—Capecitabine—breast cancer	3.28e-05	0.000251	CcSEcCtD
Mexiletine—Malaise—Doxorubicin—breast cancer	3.25e-05	0.000249	CcSEcCtD
Mexiletine—Dry mouth—Epirubicin—breast cancer	3.25e-05	0.000249	CcSEcCtD
Mexiletine—Syncope—Doxorubicin—breast cancer	3.24e-05	0.000248	CcSEcCtD
Mexiletine—Leukopenia—Doxorubicin—breast cancer	3.23e-05	0.000247	CcSEcCtD
Mexiletine—Diarrhoea—Docetaxel—breast cancer	3.23e-05	0.000247	CcSEcCtD
Mexiletine—Confusional state—Epirubicin—breast cancer	3.21e-05	0.000246	CcSEcCtD
Mexiletine—Palpitations—Doxorubicin—breast cancer	3.19e-05	0.000244	CcSEcCtD
Mexiletine—Oedema—Epirubicin—breast cancer	3.18e-05	0.000244	CcSEcCtD
Mexiletine—Hypotension—Methotrexate—breast cancer	3.18e-05	0.000243	CcSEcCtD
Mexiletine—Loss of consciousness—Doxorubicin—breast cancer	3.17e-05	0.000243	CcSEcCtD
Mexiletine—Shock—Epirubicin—breast cancer	3.13e-05	0.00024	CcSEcCtD
Mexiletine—Convulsion—Doxorubicin—breast cancer	3.13e-05	0.000239	CcSEcCtD
Mexiletine—Diarrhoea—Capecitabine—breast cancer	3.13e-05	0.000239	CcSEcCtD
Mexiletine—Dizziness—Docetaxel—breast cancer	3.12e-05	0.000239	CcSEcCtD
Mexiletine—Thrombocytopenia—Epirubicin—breast cancer	3.12e-05	0.000239	CcSEcCtD
Mexiletine—Hypertension—Doxorubicin—breast cancer	3.12e-05	0.000239	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Methotrexate—breast cancer	3.1e-05	0.000237	CcSEcCtD
Mexiletine—Hyperhidrosis—Epirubicin—breast cancer	3.08e-05	0.000236	CcSEcCtD
Mexiletine—Arthralgia—Doxorubicin—breast cancer	3.07e-05	0.000235	CcSEcCtD
Mexiletine—Chest pain—Doxorubicin—breast cancer	3.07e-05	0.000235	CcSEcCtD
Mexiletine—Paraesthesia—Methotrexate—breast cancer	3.05e-05	0.000234	CcSEcCtD
Mexiletine—Discomfort—Doxorubicin—breast cancer	3.04e-05	0.000232	CcSEcCtD
Mexiletine—Dyspnoea—Methotrexate—breast cancer	3.03e-05	0.000232	CcSEcCtD
Mexiletine—Somnolence—Methotrexate—breast cancer	3.02e-05	0.000232	CcSEcCtD
Mexiletine—Dizziness—Capecitabine—breast cancer	3.02e-05	0.000231	CcSEcCtD
Mexiletine—Dry mouth—Doxorubicin—breast cancer	3e-05	0.00023	CcSEcCtD
Mexiletine—Vomiting—Docetaxel—breast cancer	3e-05	0.00023	CcSEcCtD
Mexiletine—Dyspepsia—Methotrexate—breast cancer	2.99e-05	0.000229	CcSEcCtD
Mexiletine—Rash—Docetaxel—breast cancer	2.98e-05	0.000228	CcSEcCtD
Mexiletine—Hypotension—Epirubicin—breast cancer	2.97e-05	0.000228	CcSEcCtD
Mexiletine—Dermatitis—Docetaxel—breast cancer	2.97e-05	0.000228	CcSEcCtD
Mexiletine—Confusional state—Doxorubicin—breast cancer	2.97e-05	0.000227	CcSEcCtD
Mexiletine—Headache—Docetaxel—breast cancer	2.96e-05	0.000226	CcSEcCtD
Mexiletine—Oedema—Doxorubicin—breast cancer	2.95e-05	0.000226	CcSEcCtD
Mexiletine—Fatigue—Methotrexate—breast cancer	2.93e-05	0.000225	CcSEcCtD
Mexiletine—Pain—Methotrexate—breast cancer	2.91e-05	0.000223	CcSEcCtD
Mexiletine—Vomiting—Capecitabine—breast cancer	2.91e-05	0.000222	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Epirubicin—breast cancer	2.9e-05	0.000222	CcSEcCtD
Mexiletine—Shock—Doxorubicin—breast cancer	2.9e-05	0.000222	CcSEcCtD
Mexiletine—Thrombocytopenia—Doxorubicin—breast cancer	2.88e-05	0.000221	CcSEcCtD
Mexiletine—Rash—Capecitabine—breast cancer	2.88e-05	0.000221	CcSEcCtD
Mexiletine—Dermatitis—Capecitabine—breast cancer	2.88e-05	0.00022	CcSEcCtD
Mexiletine—Headache—Capecitabine—breast cancer	2.86e-05	0.000219	CcSEcCtD
Mexiletine—Paraesthesia—Epirubicin—breast cancer	2.86e-05	0.000219	CcSEcCtD
Mexiletine—Hyperhidrosis—Doxorubicin—breast cancer	2.85e-05	0.000218	CcSEcCtD
Mexiletine—Dyspnoea—Epirubicin—breast cancer	2.84e-05	0.000217	CcSEcCtD
Mexiletine—Somnolence—Epirubicin—breast cancer	2.83e-05	0.000217	CcSEcCtD
Mexiletine—Nausea—Docetaxel—breast cancer	2.8e-05	0.000215	CcSEcCtD
Mexiletine—Feeling abnormal—Methotrexate—breast cancer	2.8e-05	0.000215	CcSEcCtD
Mexiletine—Dyspepsia—Epirubicin—breast cancer	2.8e-05	0.000215	CcSEcCtD
Mexiletine—Gastrointestinal pain—Methotrexate—breast cancer	2.78e-05	0.000213	CcSEcCtD
Mexiletine—Hypotension—Doxorubicin—breast cancer	2.75e-05	0.000211	CcSEcCtD
Mexiletine—Fatigue—Epirubicin—breast cancer	2.74e-05	0.00021	CcSEcCtD
Mexiletine—Constipation—Epirubicin—breast cancer	2.72e-05	0.000208	CcSEcCtD
Mexiletine—Pain—Epirubicin—breast cancer	2.72e-05	0.000208	CcSEcCtD
Mexiletine—Nausea—Capecitabine—breast cancer	2.71e-05	0.000208	CcSEcCtD
Mexiletine—Body temperature increased—Methotrexate—breast cancer	2.69e-05	0.000206	CcSEcCtD
Mexiletine—Abdominal pain—Methotrexate—breast cancer	2.69e-05	0.000206	CcSEcCtD
Mexiletine—Musculoskeletal discomfort—Doxorubicin—breast cancer	2.68e-05	0.000205	CcSEcCtD
Mexiletine—Paraesthesia—Doxorubicin—breast cancer	2.64e-05	0.000202	CcSEcCtD
Mexiletine—Dyspnoea—Doxorubicin—breast cancer	2.63e-05	0.000201	CcSEcCtD
Mexiletine—Feeling abnormal—Epirubicin—breast cancer	2.62e-05	0.000201	CcSEcCtD
Mexiletine—Somnolence—Doxorubicin—breast cancer	2.62e-05	0.0002	CcSEcCtD
Mexiletine—Gastrointestinal pain—Epirubicin—breast cancer	2.6e-05	0.000199	CcSEcCtD
Mexiletine—Dyspepsia—Doxorubicin—breast cancer	2.59e-05	0.000199	CcSEcCtD
Mexiletine—Fatigue—Doxorubicin—breast cancer	2.54e-05	0.000194	CcSEcCtD
Mexiletine—Pain—Doxorubicin—breast cancer	2.52e-05	0.000193	CcSEcCtD
Mexiletine—Constipation—Doxorubicin—breast cancer	2.52e-05	0.000193	CcSEcCtD
Mexiletine—Abdominal pain—Epirubicin—breast cancer	2.52e-05	0.000193	CcSEcCtD
Mexiletine—Body temperature increased—Epirubicin—breast cancer	2.52e-05	0.000193	CcSEcCtD
Mexiletine—Hypersensitivity—Methotrexate—breast cancer	2.51e-05	0.000192	CcSEcCtD
Mexiletine—Asthenia—Methotrexate—breast cancer	2.44e-05	0.000187	CcSEcCtD
Mexiletine—Feeling abnormal—Doxorubicin—breast cancer	2.43e-05	0.000186	CcSEcCtD
Mexiletine—Gastrointestinal pain—Doxorubicin—breast cancer	2.41e-05	0.000184	CcSEcCtD
Mexiletine—Hypersensitivity—Epirubicin—breast cancer	2.35e-05	0.00018	CcSEcCtD
Mexiletine—Abdominal pain—Doxorubicin—breast cancer	2.33e-05	0.000178	CcSEcCtD
Mexiletine—Body temperature increased—Doxorubicin—breast cancer	2.33e-05	0.000178	CcSEcCtD
Mexiletine—Diarrhoea—Methotrexate—breast cancer	2.33e-05	0.000178	CcSEcCtD
Mexiletine—Asthenia—Epirubicin—breast cancer	2.28e-05	0.000175	CcSEcCtD
Mexiletine—Dizziness—Methotrexate—breast cancer	2.25e-05	0.000172	CcSEcCtD
Mexiletine—Diarrhoea—Epirubicin—breast cancer	2.18e-05	0.000167	CcSEcCtD
Mexiletine—Hypersensitivity—Doxorubicin—breast cancer	2.17e-05	0.000166	CcSEcCtD
Mexiletine—Vomiting—Methotrexate—breast cancer	2.16e-05	0.000166	CcSEcCtD
Mexiletine—Rash—Methotrexate—breast cancer	2.14e-05	0.000164	CcSEcCtD
Mexiletine—Dermatitis—Methotrexate—breast cancer	2.14e-05	0.000164	CcSEcCtD
Mexiletine—Headache—Methotrexate—breast cancer	2.13e-05	0.000163	CcSEcCtD
Mexiletine—Asthenia—Doxorubicin—breast cancer	2.11e-05	0.000162	CcSEcCtD
Mexiletine—Dizziness—Epirubicin—breast cancer	2.1e-05	0.000161	CcSEcCtD
Mexiletine—Vomiting—Epirubicin—breast cancer	2.02e-05	0.000155	CcSEcCtD
Mexiletine—Nausea—Methotrexate—breast cancer	2.02e-05	0.000155	CcSEcCtD
Mexiletine—Diarrhoea—Doxorubicin—breast cancer	2.02e-05	0.000154	CcSEcCtD
Mexiletine—Rash—Epirubicin—breast cancer	2.01e-05	0.000154	CcSEcCtD
Mexiletine—Dermatitis—Epirubicin—breast cancer	2.01e-05	0.000154	CcSEcCtD
Mexiletine—Headache—Epirubicin—breast cancer	1.99e-05	0.000153	CcSEcCtD
Mexiletine—Dizziness—Doxorubicin—breast cancer	1.95e-05	0.000149	CcSEcCtD
Mexiletine—Nausea—Epirubicin—breast cancer	1.89e-05	0.000145	CcSEcCtD
Mexiletine—Vomiting—Doxorubicin—breast cancer	1.87e-05	0.000143	CcSEcCtD
Mexiletine—Rash—Doxorubicin—breast cancer	1.86e-05	0.000142	CcSEcCtD
Mexiletine—Dermatitis—Doxorubicin—breast cancer	1.86e-05	0.000142	CcSEcCtD
Mexiletine—Headache—Doxorubicin—breast cancer	1.85e-05	0.000141	CcSEcCtD
Mexiletine—Nausea—Doxorubicin—breast cancer	1.75e-05	0.000134	CcSEcCtD
Mexiletine—CYP3A4—Metabolism—GPI—breast cancer	3.71e-06	4.37e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP3A4—breast cancer	3.71e-06	4.37e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—breast cancer	3.69e-06	4.34e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—breast cancer	3.65e-06	4.3e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP1B1—breast cancer	3.65e-06	4.29e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GPX2—breast cancer	3.64e-06	4.29e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTA2—breast cancer	3.64e-06	4.29e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP3A4—breast cancer	3.63e-06	4.28e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GPX4—breast cancer	3.6e-06	4.24e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SULT1A1—breast cancer	3.6e-06	4.24e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—DPYD—breast cancer	3.6e-06	4.23e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—MED12—breast cancer	3.6e-06	4.23e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—HSP90AA1—breast cancer	3.58e-06	4.21e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP1B1—breast cancer	3.57e-06	4.2e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ALDOA—breast cancer	3.54e-06	4.17e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ALDH7A1—breast cancer	3.54e-06	4.17e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ALDH1A1—breast cancer	3.54e-06	4.17e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTA1—breast cancer	3.51e-06	4.14e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—IDH1—breast cancer	3.51e-06	4.14e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—HSP90AA1—breast cancer	3.5e-06	4.12e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NCOA1—breast cancer	3.48e-06	4.09e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NAT2—breast cancer	3.47e-06	4.09e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NCOA3—breast cancer	3.44e-06	4.05e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—STK11—breast cancer	3.43e-06	4.04e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP19A1—breast cancer	3.43e-06	4.04e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SLC2A2—breast cancer	3.41e-06	4.02e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NCOA1—breast cancer	3.41e-06	4.01e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ADSL—breast cancer	3.39e-06	3.99e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—UMPS—breast cancer	3.39e-06	3.99e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PHGDH—breast cancer	3.39e-06	3.99e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NME1—breast cancer	3.39e-06	3.99e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—FHL2—breast cancer	3.39e-06	3.99e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—STK11—breast cancer	3.36e-06	3.95e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP19A1—breast cancer	3.36e-06	3.95e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—MTR—breast cancer	3.34e-06	3.94e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CPT1A—breast cancer	3.34e-06	3.94e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ABCG2—breast cancer	3.34e-06	3.94e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—BRIP1—breast cancer	3.33e-06	3.92e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HPSE—breast cancer	3.33e-06	3.92e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—LDHB—breast cancer	3.33e-06	3.92e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—HPGDS—breast cancer	3.28e-06	3.86e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—HBA1—breast cancer	3.26e-06	3.84e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—COMT—breast cancer	3.19e-06	3.75e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTT1—breast cancer	3.18e-06	3.74e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ACHE—breast cancer	3.18e-06	3.74e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTP1—breast cancer	3.17e-06	3.73e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTA3—breast cancer	3.15e-06	3.71e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HMMR—breast cancer	3.15e-06	3.71e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ABCC1—breast cancer	3.15e-06	3.71e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—CAV1—breast cancer	3.14e-06	3.7e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—HMOX1—breast cancer	3.13e-06	3.68e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—COMT—breast cancer	3.12e-06	3.67e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ITPR1—breast cancer	3.12e-06	3.67e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTP1—breast cancer	3.11e-06	3.66e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—HMOX1—breast cancer	3.06e-06	3.61e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ITPR1—breast cancer	3.06e-06	3.6e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PPARGC1B—breast cancer	3.05e-06	3.6e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—MED12—breast cancer	3.05e-06	3.59e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—DPYD—breast cancer	3.05e-06	3.59e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP17A1—breast cancer	3.01e-06	3.54e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ABCB1—breast cancer	3e-06	3.53e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ALDOA—breast cancer	3e-06	3.53e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTGS1—breast cancer	2.98e-06	3.51e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ENO1—breast cancer	2.98e-06	3.51e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—TYMS—breast cancer	2.95e-06	3.47e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ABCB1—breast cancer	2.94e-06	3.46e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NCOR1—breast cancer	2.91e-06	3.43e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PLA2G4A—breast cancer	2.91e-06	3.43e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GSTM1—breast cancer	2.91e-06	3.43e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NCOA3—breast cancer	2.91e-06	3.43e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SLC2A2—breast cancer	2.89e-06	3.4e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—TYMS—breast cancer	2.89e-06	3.4e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTA4—breast cancer	2.88e-06	3.4e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CA9—breast cancer	2.88e-06	3.4e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NCOA2—breast cancer	2.87e-06	3.38e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—breast cancer	2.86e-06	3.37e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PLA2G4A—breast cancer	2.85e-06	3.36e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NCOR1—breast cancer	2.85e-06	3.36e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GSTM1—breast cancer	2.85e-06	3.36e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CPT1A—breast cancer	2.83e-06	3.33e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ABCG2—breast cancer	2.83e-06	3.33e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—MTR—breast cancer	2.83e-06	3.33e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GPX2—breast cancer	2.81e-06	3.31e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTA2—breast cancer	2.81e-06	3.31e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—GPX1—breast cancer	2.79e-06	3.29e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—FASN—breast cancer	2.78e-06	3.28e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HPGDS—breast cancer	2.78e-06	3.27e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GPX4—breast cancer	2.78e-06	3.27e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SULT1A1—breast cancer	2.78e-06	3.27e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—BCHE—breast cancer	2.77e-06	3.26e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CYP1A1—breast cancer	2.76e-06	3.25e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HBA1—breast cancer	2.76e-06	3.25e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ERCC2—breast cancer	2.74e-06	3.23e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SLC5A5—breast cancer	2.74e-06	3.22e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—GPX1—breast cancer	2.73e-06	3.22e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTA1—breast cancer	2.71e-06	3.19e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—IDH1—breast cancer	2.71e-06	3.19e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CYP1A1—breast cancer	2.71e-06	3.19e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ACHE—breast cancer	2.69e-06	3.17e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTT1—breast cancer	2.69e-06	3.17e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ERCC2—breast cancer	2.68e-06	3.16e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NAT2—breast cancer	2.68e-06	3.16e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NQO1—breast cancer	2.64e-06	3.11e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—SLC2A1—breast cancer	2.64e-06	3.11e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP3A4—breast cancer	2.58e-06	3.03e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—MTHFR—breast cancer	2.58e-06	3.03e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP17A1—breast cancer	2.55e-06	3e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP1B1—breast cancer	2.53e-06	2.98e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTGS1—breast cancer	2.52e-06	2.97e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ENO1—breast cancer	2.52e-06	2.97e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—MTHFR—breast cancer	2.52e-06	2.97e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CD—breast cancer	2.52e-06	2.96e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—HSP90AA1—breast cancer	2.48e-06	2.93e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—ALB—breast cancer	2.48e-06	2.92e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP2D6—breast cancer	2.48e-06	2.91e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NCOA2—breast cancer	2.43e-06	2.86e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NCOA1—breast cancer	2.42e-06	2.85e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—STK11—breast cancer	2.38e-06	2.8e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP19A1—breast cancer	2.38e-06	2.8e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—CAV1—breast cancer	2.38e-06	2.8e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—FASN—breast cancer	2.36e-06	2.77e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—DPYD—breast cancer	2.35e-06	2.77e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—MED12—breast cancer	2.35e-06	2.77e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—BCHE—breast cancer	2.35e-06	2.76e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—CAV1—breast cancer	2.33e-06	2.74e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SLC5A5—breast cancer	2.32e-06	2.73e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ALDOA—breast cancer	2.31e-06	2.73e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NCOA3—breast cancer	2.25e-06	2.65e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NQO1—breast cancer	2.24e-06	2.64e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—SLC2A1—breast cancer	2.24e-06	2.64e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SLC2A2—breast cancer	2.23e-06	2.63e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—COMT—breast cancer	2.21e-06	2.61e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTP1—breast cancer	2.2e-06	2.6e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CB—breast cancer	2.19e-06	2.58e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ABCG2—breast cancer	2.19e-06	2.57e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CPT1A—breast cancer	2.19e-06	2.57e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—MTR—breast cancer	2.19e-06	2.57e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP3A4—breast cancer	2.18e-06	2.57e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—HMOX1—breast cancer	2.17e-06	2.56e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—breast cancer	2.17e-06	2.56e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ITPR1—breast cancer	2.17e-06	2.55e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CG—breast cancer	2.16e-06	2.55e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP1B1—breast cancer	2.15e-06	2.53e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HPGDS—breast cancer	2.14e-06	2.52e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HBA1—breast cancer	2.13e-06	2.51e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CG—breast cancer	2.12e-06	2.5e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HSP90AA1—breast cancer	2.11e-06	2.48e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ABCB1—breast cancer	2.09e-06	2.46e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTT1—breast cancer	2.08e-06	2.45e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ACHE—breast cancer	2.08e-06	2.45e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—TYMS—breast cancer	2.05e-06	2.41e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NCOA1—breast cancer	2.05e-06	2.41e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GSTM1—breast cancer	2.03e-06	2.38e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NCOR1—breast cancer	2.03e-06	2.38e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PLA2G4A—breast cancer	2.03e-06	2.38e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—STK11—breast cancer	2.02e-06	2.38e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP19A1—breast cancer	2.02e-06	2.38e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP17A1—breast cancer	1.97e-06	2.32e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ENO1—breast cancer	1.95e-06	2.29e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTGS1—breast cancer	1.95e-06	2.29e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—GPX1—breast cancer	1.94e-06	2.28e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CYP1A1—breast cancer	1.92e-06	2.26e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP2D6—breast cancer	1.91e-06	2.25e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ERCC2—breast cancer	1.9e-06	2.24e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CD—breast cancer	1.9e-06	2.24e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—breast cancer	1.89e-06	2.23e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—ALB—breast cancer	1.88e-06	2.21e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—COMT—breast cancer	1.88e-06	2.21e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NCOA2—breast cancer	1.88e-06	2.21e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTP1—breast cancer	1.87e-06	2.2e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CD—breast cancer	1.86e-06	2.19e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—HMOX1—breast cancer	1.84e-06	2.17e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—ALB—breast cancer	1.84e-06	2.17e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ITPR1—breast cancer	1.84e-06	2.16e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—FASN—breast cancer	1.82e-06	2.14e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—BCHE—breast cancer	1.81e-06	2.13e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—NOS3—breast cancer	1.8e-06	2.11e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—MTHFR—breast cancer	1.79e-06	2.11e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SLC5A5—breast cancer	1.79e-06	2.11e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ABCB1—breast cancer	1.77e-06	2.08e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—NOS3—breast cancer	1.76e-06	2.07e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—TYMS—breast cancer	1.74e-06	2.04e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—SLC2A1—breast cancer	1.73e-06	2.03e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NQO1—breast cancer	1.73e-06	2.03e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PLA2G4A—breast cancer	1.72e-06	2.02e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NCOR1—breast cancer	1.72e-06	2.02e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GSTM1—breast cancer	1.72e-06	2.02e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CB—breast cancer	1.66e-06	1.95e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP1B1—breast cancer	1.66e-06	1.95e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—CAV1—breast cancer	1.65e-06	1.94e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—GPX1—breast cancer	1.64e-06	1.93e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PTGS2—breast cancer	1.64e-06	1.93e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CYP1A1—breast cancer	1.63e-06	1.92e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HSP90AA1—breast cancer	1.62e-06	1.91e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CB—breast cancer	1.62e-06	1.91e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ERCC2—breast cancer	1.61e-06	1.9e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PTGS2—breast cancer	1.61e-06	1.89e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NCOA1—breast cancer	1.58e-06	1.86e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—STK11—breast cancer	1.56e-06	1.83e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP19A1—breast cancer	1.56e-06	1.83e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—MTHFR—breast cancer	1.52e-06	1.79e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CG—breast cancer	1.5e-06	1.77e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—COMT—breast cancer	1.45e-06	1.7e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTP1—breast cancer	1.44e-06	1.7e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PTEN—breast cancer	1.43e-06	1.69e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—HMOX1—breast cancer	1.42e-06	1.67e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ITPR1—breast cancer	1.42e-06	1.67e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PTEN—breast cancer	1.4e-06	1.65e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—CAV1—breast cancer	1.4e-06	1.65e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ABCB1—breast cancer	1.36e-06	1.61e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—TYMS—breast cancer	1.34e-06	1.58e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—breast cancer	1.34e-06	1.57e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PLA2G4A—breast cancer	1.32e-06	1.56e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GSTM1—breast cancer	1.32e-06	1.56e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NCOR1—breast cancer	1.32e-06	1.56e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CD—breast cancer	1.32e-06	1.56e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—ALB—breast cancer	1.31e-06	1.54e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CG—breast cancer	1.27e-06	1.5e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—GPX1—breast cancer	1.27e-06	1.49e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CYP1A1—breast cancer	1.26e-06	1.48e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—NOS3—breast cancer	1.25e-06	1.47e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ERCC2—breast cancer	1.25e-06	1.47e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—MTHFR—breast cancer	1.17e-06	1.38e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CB—breast cancer	1.15e-06	1.36e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTGS2—breast cancer	1.14e-06	1.34e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CD—breast cancer	1.12e-06	1.32e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—ALB—breast cancer	1.11e-06	1.3e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—CAV1—breast cancer	1.08e-06	1.27e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—NOS3—breast cancer	1.06e-06	1.25e-05	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—PIK3CA—breast cancer	1.01e-06	1.19e-05	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PTEN—breast cancer	9.96e-07	1.17e-05	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—PIK3CA—breast cancer	9.9e-07	1.17e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CG—breast cancer	9.83e-07	1.16e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CB—breast cancer	9.76e-07	1.15e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTGS2—breast cancer	9.67e-07	1.14e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CD—breast cancer	8.64e-07	1.02e-05	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—ALB—breast cancer	8.53e-07	1e-05	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PTEN—breast cancer	8.44e-07	9.93e-06	CbGpPWpGaD
Mexiletine—CYP2B6—Metabolism—AKT1—breast cancer	8.26e-07	9.72e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—NOS3—breast cancer	8.16e-07	9.61e-06	CbGpPWpGaD
Mexiletine—CYP2E1—Metabolism—AKT1—breast cancer	8.09e-07	9.52e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CB—breast cancer	7.54e-07	8.87e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTGS2—breast cancer	7.47e-07	8.79e-06	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—PIK3CA—breast cancer	7.03e-07	8.27e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PTEN—breast cancer	6.51e-07	7.67e-06	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—PIK3CA—breast cancer	5.95e-07	7.01e-06	CbGpPWpGaD
Mexiletine—CYP2D6—Metabolism—AKT1—breast cancer	5.74e-07	6.76e-06	CbGpPWpGaD
Mexiletine—CYP1A2—Metabolism—AKT1—breast cancer	4.86e-07	5.72e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—PIK3CA—breast cancer	4.59e-07	5.41e-06	CbGpPWpGaD
Mexiletine—CYP3A4—Metabolism—AKT1—breast cancer	3.75e-07	4.42e-06	CbGpPWpGaD
